Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial

被引：0

作者：

Grupp, Stephan A. ^{[1
]}

Maude, Shannon L. ^{[1
]}

Rives, Susana ^{[2
]}

Baruchel, Andre ^{[3
]}

Boyer, Michael ^{[4
]}

Bittencourt, Henrique ^{[5
]}

Bader, Peter ^{[6
]}

Buchner, Jochen ^{[7
]}

Laetsch, Theodore W. ^{[8
,9
]}

Stefanski, Heather ^{[10
]}

Myers, Gary Douglas ^{[11
]}

Qayed, Muna ^{[12
]}

Pulsipher, Michael A. ^{[13
]}

De Moerloose, Barbara ^{[14
]}

Yanik, Gregory A. ^{[15
]}

Davis, Kara L. ^{[16
]}

Martin, Paul L. ^{[17
]}

Nemecek, Eneida R. ^{[18
]}

Peters, Christina ^{[19
]}

Krueger, Joerg ^{[20
]}

Balduzzi, Adriana, Sr. ^{[21
,22
]}

Boissel, Nicolas ^{[23
]}

Mechinaud, Francoise ^{[24
]}

Leung, Mimi ^{[25
]}

Eldjerou, Lamis ^{[25
]}

Bleickardt, Eric ^{[25
]}

Mueller, Karen Thudium ^{[26
]}

Hiramatsu, Hidefumi ^{[27
]}

机构：

[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

[2] Hosp St Joan de Deu Barcelona, Dept Hematol & Oncol, Barcelona, Spain

[3] Hop St Louis, Dept Pediat, Paris, France

[4] Univ Utah, Blood & Marrow Transplant Program, Div Hematol & Hematol Malignancies, Huntsman Canc Inst, Salt Lake City, UT USA

[5] Hosp Clin, Belo Horizonte, MG, Brazil

[6] Klin Kinder & Jugendmed, Stem Cell Transplantat & Immunol, Frankfurt, Germany

[7] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway

[8] Univ Texas Southwestern Med Ctr, Dallas, TX USA

[9] Childrens Hlth, Pauline Allen Gill Ctr Canc & Blood Disorders, Dallas, TX USA

[10] Univ Minnesota, Pediat Blood & Marrow Transplantat, Minneapolis, MN USA

[11] Childrens Mercy Hosp, Kansas City, MO 64108 USA

[12] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA

[13] Childrens Hosp Los Angeles, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA

[14] Ghent Univ Hosp, Pediat Hematol Oncol & Stem Cell Transplantat, Ghent, Belgium

[15] Univ Michigan, Blood & Marrow Transplantat Program, Ann Arbor, MI 48109 USA

[16] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA

[17] Duke Univ, Med Ctr, Pediat Blood & Marrow Transplantat, Durham, NC USA

[18] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[19] St Anna Childrens Hosp, Stem Cell Transplantat Unit, Vienna, Austria

[20] Hosp Sick Children, Div Hematol Oncol BMT, Toronto, ON, Canada

[21] San Gerardo Hosp, HSCT Pediat Unit, Monza, Italy

[22] San Gerardo Hosp, Lab Cell Therapy S Verri, Monza, Italy

[23] Hop St Louis Univ, Paris, France

[24] Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia

[25] Novartis Pharmaceut, E Hanover, NJ USA

[26] Novartis Inst BioMed Res, E Hanover, NJ USA

[27] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

170

引用

页数：2

共 50 条

[1] Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
Laetsch, Theodore W.
Maude, Shannon L.
Rives, Susana
Hiramatsu., Hidefumi
Bittencourt., Henrique
Bader, Peter.
Baruchel, Andre
Boyer, Michael
De Moerloose, Barbara
Qayed, Muna
Buechner, Jochen
Pulsipher, Michael A.
Myers, Gary Douglas
Stefanski, Heather E.
Martin, Paul L.
Nemecek, Eneida
Peters, Christina
Yanik, Gregory
Khaw, Seong Lin
Davis, Kara L.
Krueger, Joerg
Balduzzi, Adriana
Boissel, Nicolas
Tiwari, Ranjan
O'Donovan, Darragh
Grupp, Stephan A.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1664 - +
[2] Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia
Grupp, Stephan A.
Maude, Shannon L.
Rives, Susana
Baruchel, Andre
Boyer, Michael W.
Bittencourt, Henrique
Bader, Peter
Buchner, Jochen
Laetsch, Theodore W.
Stefanski, Heather
Myers, Gary Douglas
Qayed, Muna
Pulsipher, Michael A.
De Moerloose, Barbara
Yanik, Gregory A.
Davis, Kara L.
Martin, Paul L.
Nemecek, Eneida R.
Peters, Christina
Krueger, Joerg
Balduzzi, Adriana
Boissel, Nicolas
Mechinaud, Francoise Marie
Leung, Mimi
Eldjerou, Lamis K.
Yi, Lan
Mueller, Karen Thudium
Bleickardt, Eric
Hiramatsu, Hidefumi
BLOOD, 2018, 132
[3] More Updates to Come of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial: Could the Statistical Methodology Be Further Improved?
Tong, Wing H.
Mertens, Bart J.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13) : 2450 - 2451
[4] More Updates to Come of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial: Could the Statistical Methodology Be Further Improved? Reply
Laetsch, Theodore W.
Tiwari, Ranjan
Grupp, Stephan A.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13)
[5] Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia
Laetsch, Theodore W.
Maude, Shannon L.
Balduzzi, Adriana
Rives, Susana
Bittencourt, Henrique
Boyer, Michael W.
Buechner, Jochen
De Moerloose, Barbara
Qayed, Muna
Phillips, Christine L.
Pulsipher, Michael A.
Hiramatsu, Hidefumi
Tiwari, Ranjan
Grupp, Stephan A.
LEUKEMIA, 2022, 36 (06) : 1508 - 1515
[6] Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia
Theodore W. Laetsch
Shannon L. Maude
Adriana Balduzzi
Susana Rives
Henrique Bittencourt
Michael W. Boyer
Jochen Buechner
Barbara De Moerloose
Muna Qayed
Christine L. Phillips
Michael A. Pulsipher
Hidefumi Hiramatsu
Ranjan Tiwari
Stephan A. Grupp
Leukemia, 2022, 36 : 1508 - 1515
[7] Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan
Wakase, Shiho
Teshima, Takanori
Zhang, Jie
Ma, Qiufei
Watanabe, Yoko
Yang, Hongbo
Qi, Cynthia Z.
Chai, Xinglei
Xie, Yanwen
Wu, Eric Q.
Igarashi, Ataru
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 241.e1 - 241.e11
[8] Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
Hidefumi Hiramatsu
Souichi Adachi
Katsutsugu Umeda
Itaru Kato
Lamis Eldjerou
Andrea Chassot Agostinho
Kazuto Natsume
Kota Tokushige
Yoko Watanabe
Stephan A. Grupp
International Journal of Hematology, 2020, 111 : 303 - 310
[9] Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
Hiramatsu, Hidefumi
Adachi, Souichi
Umeda, Katsutsugu
Kato, Itaru
Eldjerou, Lamis
Agostinho, Andrea Chassot
Natsume, Kazuto
Tokushige, Kota
Watanabe, Yoko
Grupp, Stephan A.
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (02) : 303 - 310
[10] Impact of tisagenlecleucel product attributes on clinical outcomes in pediatric and young adult patients with relapsed or refractory acute lymphoblastic leukemia (r/r ALL).
Gershgorin, Irina
Waldron, Edward R.
Grupp, Stephan A.
Levine, John E.
Pulsipher, Michael A.
Davies, Stella M.
Myers, G. Doug
Jeschke, Margit
Engels, Boris
del Corral, Chris
Baruchel, Andre
CANCER RESEARCH, 2021, 81 (13)

← 1 2 3 4 5 →